The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Medvedev V.E.

Peoples Friendship University of Russian

Frolova V.I.

RUDN University

Gushanskaya E.V.

Peoples Friendship University of Russian

Kotova O.V.

Medical Institute of Peoples’ Friendship University;
International Society for the Study of Stress «Stress under control»

Zujkova N.L.

Medical Institute of Peoples’ Friendship University

Palin A.V.

RUDN University

Astenic disorders within the framework of post-covid syndrome

Authors:

Medvedev V.E., Frolova V.I., Gushanskaya E.V., Kotova O.V., Zujkova N.L., Palin A.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4): 152‑158

DOI: 10.17116/jnevro2021121041152

Read: 5140 times

Contact the author
Table of contents

ASTENIC DISORDERS WITHIN THE FRAMEWORK OF POST-COVID SYNDROME
ASTENIC DISORDERS WITHIN THE FRAMEWORK OF POST-COVID SYNDROME

To cite this article:

Medvedev VE, Frolova VI, Gushanskaya EV, Kotova OV, Zujkova NL, Palin AV. Astenic disorders within the framework of post-covid syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4):152‑158. (In Russ.)
https://doi.org/10.17116/jnevro2021121041152

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
Prediction of mortality in severe ischemic stroke during COVID-19 in patients with multiorgan dysfunction. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):120-127
Sleep diso­rders after COVID-19 in patients with primary headaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):127-132
Effe­ctiveness and tole­rability of agomelatine (Valdoxan) in the treatment of depression after COVID-19 (TELESFOR study). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):90-98
Chro­nic obstructive pulmonary disease (COPD 2024). Clinical guidelines (short version). Journal of Respiratory Medi­cine. 2025;(2):5-16
Mathematical mode­ling of outcomes in patients with clinical combination of ischemic stroke and COVID-19 complicated by multiple organ failure. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):42-49
Atte­ndance of oral surgeons per one inha­bitant per year in the subjects of the Russian Fede­ration in 2017—2023. Stomatology. 2025;(3):53-56
Atte­ndance of dental surgeons for diseases in the Russian Fede­ration in 2017—2023. Stomatology. 2025;(4):62-65
Sarcoid reaction with focal inte­rstitial fibrosis in a COVID-19 patient with persistence of Sars-Cov-2 virus nucleocapsid and adhe­sion proteins in sarcoid granulomas and lung tissue. Russian Journal of Archive of Pathology. 2025;(4):54-57
Community-acquired pneumonia in adults. Clinical guidelines 2024 (short version). Journal of Respiratory Medi­cine. 2025;(3):6-18
Abstract:

The direct neurotropic and neurotoxic effect of the SARS-CoV-2 virus on the central nervous system, as well as the stressful effect of various factors of the COVID-19 pandemic, contribute to the development of the so-called post-COVID syndrome. The clinical picture of the syndrome includes asthenic, anxiety-asthenic, and depressive manifestations. When prescribing psychopharmacotherapy to patients who have undergone COVID-19, it is recommended to assess the potential benefits and risks in the aspect of using drugs not only with therapeutic antiasthenic and anxiolytic properties, but with minimally expressed undesirable effects and adverse drug interactions.

Keywords:

pandemic
COVID-19
asthenic disorders
therapy
anvifen

Authors:

Medvedev V.E.

Peoples Friendship University of Russian

Frolova V.I.

RUDN University

Gushanskaya E.V.

Peoples Friendship University of Russian

Kotova O.V.

Medical Institute of Peoples’ Friendship University;
International Society for the Study of Stress «Stress under control»

Zujkova N.L.

Medical Institute of Peoples’ Friendship University

Palin A.V.

RUDN University

Received:

19.02.2021

Accepted:

02.03.2021

Close metadata

References:

  1. Al-Samkari H, Leaf RK, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136(4):489-500.  https://doi.org/10.1182/blood.2020006520
  2. Amraei R, Rahimi N. COVID-19, Renin-Angiotensin System and Endot-helial Dysfunction. Cells. 2020;9(7):1652. https://doi.org/10.3390/cells9071652
  3. Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Car-diol. 2020;75(23):2950-2973. https://doi.org/10.1016/j.jacc.2020.04.031
  4. Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric pre-sentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611-627.  https://doi.org/10.1016/S2215-0366(20)30203-0
  5. Chaná-Cuevas P, Salles-Gándara P, Rojas-Fernandez A, et al. The Potential Role of SARS-COV-2 in the Pathogenesis of Parkinson’s Disease. FrontNeurol. 2020;11:1044. https://doi.org/10.3389/fneur.2020.01044
  6. Nanda S, Handa R, Prasad A, Anand R, et al. Covid-19 associated Guillain-Barre Syndrome: Contrasting tale of four patients from a tertiary care cent-re in India. Am J Emerg Med. 2020;S0735-6757(20)30823-8.  https://doi.org/10.1016/j.ajem.2020.09.029
  7. Goldberg JF. Psychiatry’s niche role in the COVIDE19 pandemic. J Clin Psychiatry. 2020;81(3):20com13363. https://doi.org/10.4088/JCP.20com13363
  8. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92:6:552-555.  https://doi.org/10.1002/jmv.25728
  9. Yao H, Chen JH, Xu YF. Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry. 2020;7(4):e21.  https://doi.org/10.1016/S2215-0366(20)30090-0
  10. Medvedev VE, Dogotar OA. COVID-19 and mental health: challenges and first conclusions. Nevrologiya, Neiropsikhiatriya, Psikhosomatika. 2020;12(6):4-10. (In Russ.) https://doi.org/10.14412/2074-2711-2020-6-4-10
  11. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The Psychological Impact of Quarantine and How To Reduce It: Rapid Review of the Evidence. The Lancet. 2020;395(10227):912-920.  https://doi.org/10.1016/S0140-6736(20)30460-8
  12. Qiu J, Shen B, Zhao M, et al. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. General Psychiatry. 2020;33:e100213. https://doi.org/10.1136/gpsych-2020-100213corr1
  13. Figueroa CA, Aguilera A. The Need for a Mental Health Technology Re-volution in the COVID-19 Pandemic. Front Psychiatry. 2020;11:523. 
  14. Ozamiz-Etxebarria N, Dosil-Santamaria M, Picaza-Gorrochategui M, et al. Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in the northern Spain. Cad Saude Publica. 2020;36(4):e00054020. https://doi.org/10.1590/0102-311X00054020
  15. Panchal N. The Implications of COVID-19 for Mental Health and Substance Use, KFF, 2020.
  16. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-1034. https://doi.org/10.1016/S0140-6736(20)30628-0
  17. Medvedev VE, Korovyakova EA, Frolova VI, Gushanskaya EV. Antidepressant therapy in patients with cardiovascular diseases. Nevrologiya, Neiropsikhiatriya, Psikhosomatika. 2019;11(1):131-140. (In Russ.). https://doi.org/10.14412/2074-2711-2019-1-131-140
  18. Steptoe A, Shankar A, Demakakos P, et al. Social isolation, loneliness, and all cause mortality in older men and women. Proc Natl AcadSci USA. 2013;110(15):5797-5801. https://doi.org/10.1073/pnas.1219686110
  19. Ahorsu DK, Lin CY, Pakpour AH. The Association Between Health Status and Insomnia, Mental Health, and Preventive Behaviors: The Mediating Role of Fear of COVID-19. Gerontol Geriatr Med. 2020;6:2333721420966081. https://doi.org/10.1177/2333721420966081
  20. Choi EH, Hui BH, Wan EF. Depression and Anxiety in Hong Kong during COVID-19. Int J Environ Res Public Health. 2020;17(10):3740. https://doi.org/10.3390/ijerph17103740
  21. Dong L, Bouey J. Public Mental Health Crisis during COVID-19 Pandemic, China. Emerg Infect Dis. 2020;26.  https://doi.org/10.3201/eid2607.202407
  22. Pappa S, Ntella V, Giannakas T, et al. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis. Brain Behav Immun. 2020;88:901-907.  https://doi.org/10.1016/j.bbi.2020.05.026
  23. Stanton R, To QG, Khalesi S, et al. Depression, Anxiety and Stress during COVID-19: Associations with Changes in Physical Activity, Sleep, Tobacco and Alcohol Use in Australian Adults. Int J Environ Res Public Health. 2020;17(11):4065. https://doi.org/10.3390/ijerph17114065
  24. Stein MB. COVID-19 and Anxiety and Depression in 2020. Depress Anxiety. 2020;37:302.  https://doi.org/10.1002/da.22870
  25. Yang Y, Li W, Zhang Q, Zhang L, Cheung T, Xiang Y-T. Mental health services for older adults in China during the COVID-19 outbreak. Lancet Psychiatry. 2020;7(4):e19.  https://doi.org/10.1016/s2215-0366(20)30079-1
  26. Lee SA, Jobe MC, Mathis AA, et al. Incremental validity of coronaphobia: Coronavirus anxiety explains depression, generalized anxiety, and death anxiety. J Anxiety Disord. 2020;74:102268. https://doi.org/10.1016/j.janxdis.2020.102268
  27. Ozdin S, Ozdin SB. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: The importance of gender. Int J Soc Psychiatry. 2020;66(5):504-511.  https://doi.org/10.1177/0020764020927051
  28. World Health Organization. Mental Health and Psychosocial Considerations During COVID-19 Outbreak. 2020. https://who.sprinklr.com/
  29. Agamamedova IN, Bannikov GS, Keshhjan KL, Krjukov VV, Pishhikova LE, Poljanskij DA, Ponizovskij PA, Shmukler AB, Shport SV. Psihicheskie reakcii i narushenija povedenija u lic s COVID-19. Informacionnoe pis’mo. M. 2020;9. (In Russ.). https://www.elibrary.ru/item.asp?id=42724333
  30. Sorokin MJu, Kas’janov ED, Rukavishnikov GV, Makarevich OV, Neznanov NG, Lutova NB, i dr. Structure of anxiety associated with covid-19 pandemic: the online survey results. Vestnik RGMU. 2020;3. (In Russ.). https://doi.org/10.24075/vrgmu.2020.030
  31. Petrova NN, Morozov PV, Markin AV, Bekker RA, Bykov JuV. The COVID-19 pandemic: challenges of our times, with discussion on the latest data regarding an issue of rational psychopharmacotherapy choices in patients with SARS-CoV-2 infection. Psihiatrija i Psihofarmakoterapija. 2020;6:8-24. (In Russ.).
  32. Dobrushina OR, Medvedev VE. Combined therapy of neurasthenia in general medical practice. Consilium Medicum. 2016;18(2):95-99. (In Russ.).
  33. Li W, Yang Y, Liu ZH, Zhao Y-J, Zhang Q, Zhang L, et al. Progression of Mental Health Services during the COVID-19 Outbreak in China. Int J Biol Sci. 2020;16(10):1732-1728. https://doi.org/10.7150/ijbs.45120
  34. American Psychiatric Association (APA). Telepsychiatry Practice Guidelines. Available online April, 23 2020. https://www.psychiatry.org/psychiatrists/practice/telepsychiatry/blog/apa-resources-on-telepsychiatry-and-covid-19
  35. Kardashjan RA, Dobrushina OR, Medvedev VE. Rapid relief of neurasthenic symptoms in general medical practice. Lechashhij Vrach. 2015;12:63-67. (In Russ.).
  36. Medvedev VE. Afobazol in treatment of anxiety and mixed anxiety and depressive disorders in patients with cardiovascular diseases. Psihiatrija i Psihofarmakoterapija im. P.B. Gannushkina. 2015;5-6:34-41. (In Russ.).
  37. Mosolov SN. Psychiatric Services Strategies During the COVID-19 Pandemic. Sovremennaja Terapija Psihicheskih Rasstrojstv. 2020;2. (In Russ.). https://doi.org/10.21265/PSYPH.2020.53.59536
  38. Avedisova AS. New domestic nootropic Nooclerin in the treatment of asthenia and other diseases. Farmateka. 2005;6:51-54. (In Russ.).
  39. Zujkova NL, Israeljan AJu, Gushanskaja EV, Medvedev VE. Cerebrolysin in the treatment of depressions. Psihiatrija i Psihofarmakoterapija. 2013;1:41-46. (In Russ.).
  40. Medvedev VE. New possibilities for the treatment of asthenic disorders in psychiatric, neurological, and somatic practice. Psihiatrija i Psihofarmakoterapija. 2013;4:53-59. (In Russ.).
  41. Medvedev VE, Zverev KV, Epifanov AV, Larceva OA, Zujkova NL, Frolova VI. Possibilities of nootropic therapy for borderline mental disorders in patients after acute coronary syndrome in a cardiological hospital. Arhiv’ Vnutrennej Mediciny. 2013;1:40-48. (In Russ.).
  42. Di Sabato DJ, Quan N, Godbout JP. Neuroinflammation: the devil is in the details. J Neurochem. 2016;139(suppl 2):136-153.  https://doi.org/10.1111/jnc.13607
  43. Bagli E, Goussia A, Moschos MM, Agnantis N, Kitsos G. Natural compounds and neuroprotection: Mechanisms of action and novel delivery systems. In Vivo. 2016;30:535-547. 
  44. Medvedev VE. Efficacy and tolerability of contemporary antidepressants: results of network meta-analyses and Russian experience. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2018;118(11):109-117. (In Russ.). https://doi.org/10.17116/jnevro2018118111109
  45. Medvedev VE, Frolova VI, Kardashjan RA. Contemporary mental health care models and mental disorders treatment strategies. Arhiv’ Vnutrennej Mediciny. 2015;6:73-78. (In Russ.).
  46. Medvedev VE, Frolova VI, Epifanov AV. New possibilities of pharmacotherapy in cardiovascular patients with mental disorders. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2014;9:30-37. (In Russ.).
  47. Medvedev VE, Chobanu IK, Frolova VI, Zujkova NL, Epifanov AV. The effectiveness of psychopharmacotherapy and psychotherapy in patients with cardiovascular diseases. Arhiv’ Vnutrennej Mediciny. 2013;5:61-66. (In Russ.).
  48. Medvedev VE. Therapy of anxiety-depressive disorders in patients with a therapeutic profile. Psihiatrija i Psihofarmakoterapija. 2015;1:21-30. (In Russ.).
  49. Medvedev VE, Ter-Israeljan AJu, Frolova VI, Gushanskaja EV, Burno AM, Nekrasova SV, Salyncev IV, Zujkova NL. Optimization of the treatment of mental disorders with a multisyndromic clinical picture. Psihiatrija i Psihofarmakoterapija. 2020;1:23-27. (In Russ.).
  50. Ngo DH, Vo TS. An Updated Review on Pharmaceutical Properties of Gamma Aminobutyric Acid. Molecules. 2019;24(15):2678. https://doi.org/10.3390/molecules24152678
  51. Mann EO, Kohl MM, Paulsen O. Distinct roles of GABA(A) and GABA(B) receptors in balancing and terminating persistent cortical activity. J Neurosci. 2009;29(23):7513-7518. https://doi.org/10.1523/JNEUROSCI.6162-08.2009
  52. Chuang CY, Shi YC, You HP, et al. Antidepressant effect of GABA-rich monascusfermented product on forced swimming rat model. J Agric Food Chem. 2011;59(7):3027-3034. Epub 2011 Mar 4. 18.  https://doi.org/10.1021/jf104239m
  53. Yamatsu A, Yamashita Y, Pandharipande T, et al. Effect of oral γ-aminobutyric acid (GABA) administration on sleep and its absorption in humans. Food Sci Biotechnol. 2016;25(2):547-551. eCollection 2016. https://doi.org/10.1007/s10068-016-0076-9
  54. Crowley T, Cryan JF, Downer EJ, O’Leary OF. Inhibiting neuroinflammation: The role and therapeutic potential of GABA in neuroimmune interactions. Brain Behav Immun. 2016;54:260-277. Epub 2016 Feb 3. 9.  https://doi.org/10.1016/j.bbi.2016.02.001
  55. Wu C, Qin X, Du H, et al. The immunological function of GABAergic system. Frontiers in Bioscience (Landmark Edition). 2017;22:1162-1172. https://doi.org/10.2741/4573
  56. Dobrushina OR, Medvedev VE. The efficacy and safety of combination therapy of asthenic state with piracetam and B vitamins in the overall health network. Consilium Medicum. 2016;9(18):159-163. (In Russ.).
  57. Cho YR, Chang JY, Chang HC. Production of gamma-aminobutyric acid (GABA) by Lactobacillus buchneri isolated from kimchi and its neuroprotective effect on neuronal cells. J Microbiol Biotechnol. 2007;17(1):104-9. 
  58. Li W, Wei M, Wu J, et al. Novel fermented chickpea milk with enhanced level of γ-aminobutyric acid and neuroprotective effect on PC12 cells. Peer J. 2016;4:e2292. eCollection 2016. https://doi.org/10.7717/peerj.2292
  59. Zhou C, Li C, Yu HM, et al. Neuroprotection of gamma-aminobutyric acid receptor agonists via enhancing neuronal nitric oxide synthase (Ser847) phosphorylation through increased neuronal nitric oxide synthase and PSD95 interaction and inhibited protein phosphatase activity in cerebral ischemia. J Neurosci Res. 2008;86(13):2973-2983. https://doi.org/10.1002/jnr.21728
  60. Liu L, Li CJ, Lu Y, et al. Baclofen mediates neuroprotection on hippocampal CA1 pyramidal cells through the regulation of autophagy under chronic cerebral hypoperfusion. Sci Rep. 2015;5:14474. https://doi.org/10.1038/srep14474
  61. Wei XW, Yan H, Xu B, et al. Neuroprotection of co-activation of GABA receptors by preventing caspase-3 denitrosylation in KA-induced seizures. Brain Res Bull. 2012;88(6):617-623. Epub 2012. https://doi.org/10.1016/j.brainresbull.2012.05.008
  62. Okada T, Sugishita T, Murakami T, et al. Effect of the defatted rice germ enriched with GABA for sleeplessness, depression, autonomic disorder by oral administration. J Jpn Soc Food Sci. 2000;47(8):596-603.  https://doi.org/10.3136/nskkk.47.596
  63. Chuang CY, Shi YC, You HP, et al. Antidepressant effect of GABA-rich monascusfermented product on forced swimming rat model. J Agric Food Chem. 2011;59(7):3027-3034. https://doi.org/10.1021/jf104239m
  64. Yamatsu A, Yamashita Y, Pandharipande T, et al. Effect of oral γ-aminobutyric acid (GABA) administration on sleep and its absorption in humans. Food Sci Biotechnol. 2016;25(2):547-551. eCollection 2016. https://doi.org/10.1007/s10068-016-0076-9
  65. Kim S, Jo K, Hong KB, et al. GABA and l-theanine mixture decreases sleep latency and improves NREM sleep. Pharm Biol. 2019;57(1):65-73.  https://doi.org/10.1080/13880209.2018.1557698
  66. Abdou AM, Higashiguchi S, Horie K, et al. Relaxation and immunity enhancement effect of gamma-aminobutyric acid (GABA) administration in humans. Biofactors. 2006;26(3):201-208.  https://doi.org/10.1002/biof.5520260305
  67. Reid SNS, Ryu JK, Kim Y, Jeon BH. The effects of fermented Laminaria japonica on short-term working memory and physical fitness in the elderly. Evid Based Complement Alternat Med. 2018;2018:1764038. eCollection 2018. https://doi.org/10.1155/2018/1764038
  68. Reid SNS, Ryu JK, Kim YS, Jeon BH. GABA-enriched fermented Laminaria japonica improves cognitive impairment and neuroplasticity in scopolamine- and ethanol-induced dementia model mice. Nutr Res Pract. 2018;12(3):199-207.  https://doi.org/10.4162/nrp.2018.12.3.199
  69. Choi WC, Reid SNS, Ryu JK, et al. Effects of γ-aminobutyric acid-enriched fermented sea tangle (Laminaria japonica) on brain derived neurotrophic factor-related muscle growth and lipolysis in middle aged women. Algae. 2016;31(2):175-187.  https://doi.org/10.4490/algae.2016.31.6.12
  70. Esin RG, Esin OR, Shamsutdinova RF. Modern approaches to the correction of maladaptive (psycho-vegetative) disorders in children and adolescents with tension headaches. Pediatriya. Zhurnal im. G.N. Speranskogo. 2015;94(1):106-112. (In Russ.).
  71. Di Sabato DJ, Quan N, Godbout JP. Neuroinflammation: the devil is in the details. J Neurochem. 2016;139(suppl 2):136-153.  https://doi.org/10.1111/jnc.13607
  72. Crowley T, Cryan JF, Downer EJ, O’Leary OF. Inhibiting neuroinflammation: The role and therapeutic potential of GABA in neuroimmune interactions. Brain Behav Immun. 2016;54:260-277. Epub 2016 Feb 3.  https://doi.org/10.1016/j.bbi.2016.02.001
  73. Takano K, Yatabe MS, Abe A, et al. Characteristic expressions of GABA receptors and GABA producing/transporting molecules in rat kidney. PLoS One. 2014;9(9):e105835. eCollection 2014. https://doi.org/10.1371/journal.pone.0105835
  74. Esin OR. Treatment of Tension-Type Headaches in Adolescents (14—15 Years Old): the Efficacy of Aminophenylbutyric Acid Hydrochloride. BioNanoScience. 2018;8(1):418-422.  https://doi.org/10.1007/s12668-018-0507-6
  75. Esin OR, Khairullin IK, Esin RG, Tokareva NV. Tension type headache: GABAergic drug anvifen efficacy. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2016;116(2): 58-61. (In Russ.).
  76. Esin RG, Khairullin IK, Mukhametova ER, Esin OR. Persistent postural-perceptual dizziness. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2017;117(4):28-33. (In Russ.). https://doi.org/10.17116/jnevro20171174128-33
  77. Lukushkina EF, Karpovich EI, Chaban OD. Aminophenylbutyric acid (Anvifen): clinical and pharmacological aspects and application experience in pediatric neurology. RMZh. Pediatrija. 2014;3:3-6. (In Russ.).
  78. Drobizhev MYu, Fedotova AV, Kikta SV. Treatment of asthenia. Is it possible to offer something new? RMJ. 2017;9:1-1. (In Russ.).
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.